Kristian Reich

Insider Reports History

Location
Zug, Switzerland
Signature
/s/ Matthias Bodenstedt, Attorney-in-fact for Kristian Reich
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kristian Reich:

Company Role Class Num Shares Value Price $ Report Date Ownership
MoonLake Immunotherapeutics Chief Scientific Officer Class A ordinary shares, par value $0.0001 per share 2,974,551 $41,048,803 $13.80 19 Dec 2025 Indirect
MoonLake Immunotherapeutics Chief Scientific Officer Class A ordinary shares, par value $0.0001 per share 35,389 $488,368 $13.80 19 Dec 2025 Direct
MoonLake Immunotherapeutics Chief Scientific Officer Stock Option (Right to Buy) 520,342 07 Jan 2026 Direct
MoonLake Immunotherapeutics Chief Scientific Officer Class C ordinary shares, par value $0.0001 per share 0 19 Dec 2025 Direct
MoonLake Immunotherapeutics Chief Scientific Officer Common shares, par value CHF 0.10 per share, of MoonLake AG 0 19 Dec 2025 Direct

Insider Reports Filed by Kristian Reich

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MLTX MoonLake Immunotherapeutics 07 Jan 2026 1 $0 4 Chief Scientific Officer 09 Jan 2026, 16:01
MLTX MoonLake Immunotherapeutics 19 Dec 2025 3 $0 4 Chief Scientific Officer 22 Dec 2025, 16:02
MLTX MoonLake Immunotherapeutics 08 Dec 2025 2 -$3,012,462 4 Chief Scientific Officer 10 Dec 2025, 16:29
MLTX MoonLake Immunotherapeutics 02 Sep 2025 3 $0 4 Chief Scientific Officer 04 Sep 2025, 16:01
MLTX MoonLake Immunotherapeutics 27 Feb 2025 1 $0 4 Chief Scientific Officer 03 Mar 2025, 21:07
MLTX MoonLake Immunotherapeutics 20 Jan 2025 3 $0 4 Chief Scientific Officer 22 Jan 2025, 21:55
MLTX MoonLake Immunotherapeutics 27 Feb 2024 4 -$6,540,710 4 Chief Scientific Officer 29 Feb 2024, 19:53
MLTX MoonLake Immunotherapeutics 20 Feb 2024 4 -$1,208,418 4 Chief Scientific Officer 22 Feb 2024, 18:32
MLTX MoonLake Immunotherapeutics 14 Feb 2024 6 -$3,654,800 4 Chief Scientific Officer 16 Feb 2024, 18:02
MLTX MoonLake Immunotherapeutics 01 Oct 2023 6 $0 4 Chief Scientific Officer 03 Oct 2023, 19:27
MLTX MoonLake Immunotherapeutics 05 Apr 2023 6 $0 4 Chief Scientific Officer 07 Apr 2023, 16:05
MLTX MoonLake Immunotherapeutics 05 Apr 2022 0 $0 3 Chief Scientific Officer 15 Apr 2022, 16:07